Correlation Between Im Cannabis and Veritas Pharma
Can any of the company-specific risk be diversified away by investing in both Im Cannabis and Veritas Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Im Cannabis and Veritas Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Im Cannabis Corp and Veritas Pharma, you can compare the effects of market volatilities on Im Cannabis and Veritas Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Im Cannabis with a short position of Veritas Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Im Cannabis and Veritas Pharma.
Diversification Opportunities for Im Cannabis and Veritas Pharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between IMCC and Veritas is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Im Cannabis Corp and Veritas Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Veritas Pharma and Im Cannabis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Im Cannabis Corp are associated (or correlated) with Veritas Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Veritas Pharma has no effect on the direction of Im Cannabis i.e., Im Cannabis and Veritas Pharma go up and down completely randomly.
Pair Corralation between Im Cannabis and Veritas Pharma
If you would invest 235.00 in Im Cannabis Corp on September 4, 2024 and sell it today you would earn a total of 73.00 from holding Im Cannabis Corp or generate 31.06% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 98.44% |
Values | Daily Returns |
Im Cannabis Corp vs. Veritas Pharma
Performance |
Timeline |
Im Cannabis Corp |
Veritas Pharma |
Im Cannabis and Veritas Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Im Cannabis and Veritas Pharma
The main advantage of trading using opposite Im Cannabis and Veritas Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Im Cannabis position performs unexpectedly, Veritas Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Veritas Pharma will offset losses from the drop in Veritas Pharma's long position.Im Cannabis vs. Clever Leaves Holdings | Im Cannabis vs. Khiron Life Sciences | Im Cannabis vs. Allied Corp | Im Cannabis vs. Biofrontera |
Veritas Pharma vs. Cann American Corp | Veritas Pharma vs. Genomma Lab Internacional | Veritas Pharma vs. Speakeasy Cannabis Club | Veritas Pharma vs. Benchmark Botanics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |